Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal

Han Xian-Zhi; Zhang Shu-Feng; Yi Jia-Yin; Wang Bin; Sun Hui-Qing

doi:10.1515/biol-2020-0044

Open Life Sciences (Jun 2020)

Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal

Han Xian-Zhi,
Zhang Shu-Feng,
Yi Jia-Yin,
Wang Bin,
Sun Hui-Qing

Affiliations

Han Xian-Zhi: Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Zhang Shu-Feng: Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Yi Jia-Yin: Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Wang Bin: Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Sun Hui-Qing: Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

DOI: https://doi.org/10.1515/biol-2020-0044
Journal volume & issue: Vol. 15, no. 1
pp. 418 – 422

Abstract

Read online

The objective of this study is to detect the liver stiffness of hepatitis B virus (HBV)-infected patients with an alanine aminotransferase (ALT) level of <2 upper limit of normal (2ULN) by FibroScan and compare histological changes to assess the progression of liver lesions and its test results.

Published in Open Life Sciences

ISSN: 2391-5412 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Science: Biology (General)
Website: http://www.degruyter.com/view/j/biol

About the journal

Abstract

Keywords